Tissue Retained Earnings from 2010 to 2025

TRX Stock   58.50  1.50  2.50%   
Tissue Regenix's Retained Earnings are decreasing over the years with slightly volatile fluctuation. Overall, Retained Earnings are projected to go to about -105.8 M this year. Retained Earnings is the cumulative amount of net income that Tissue Regenix Group retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals
 
Retained Earnings  
First Reported
2008-06-30
Previous Quarter
-92.3 M
Current Value
-123.8 M
Quarterly Volatility
37.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tissue Regenix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tissue Regenix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 1 M or Selling General Administrative of 10.2 M, as well as many indicators such as . Tissue financial statements analysis is a perfect complement when working with Tissue Regenix Valuation or Volatility modules.
  
This module can also supplement various Tissue Regenix Technical models . Check out the analysis of Tissue Regenix Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Tissue Stock

Tissue Regenix financial ratios help investors to determine whether Tissue Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tissue with respect to the benefits of owning Tissue Regenix security.